COc1cccc(CCN2C(=O)C(=O)N([C@@H](CNCc3ccccc3)Cc3ccccc3F)C[C@@H]2C(C)(C)C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?